GENETIC ANALYSIS AND FERRING PHARMACEUTICALS ANNOUNCE A COLLABORATION TO DEVELOP A NEW MICROBIOME RAPID DIAGNOSTIC TEST December 21, 2024
Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility October 3, 2024
Ferring Demonstrates Effectiveness of a Treat-to-Target Approach in Mild-to-Moderate Ulcerative Colitis in First Major Study October 1, 2024
